- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ASCO 2018: highlights in HER2-positive metastatic breast cancer ; day:11 ; month:10 ; year:2018 ; pages:1-4
Magazine of European Medical Oncology ; (11.10.2018), 1-4
- Urheber
-
Bartsch, Rupert
- Beteiligte Personen und Organisationen
-
Bergen, Elisabeth
SpringerLink (Online service)
- DOI
-
10.1007/s12254-018-0441-x
- URN
-
urn:nbn:de:101:1-2018112004560436464465
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bartsch, Rupert
- Bergen, Elisabeth
- SpringerLink (Online service)
Ähnliche Objekte (12)
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies
ASCO 2017: highlights in breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies
ASCO 2017: highlights in breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies